Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring Impact Factor, Indexing, Ranking

Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring Impact Factor, Indexing, Ranking

Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring (ADDADM) is a scholarly journal dedicated to publishing research in the field of Medicine. John Wiley and Sons is the publisher of this esteemed journal. and its abbreviated form is Alzheimers Dement (Amst).


Aim and Scope

Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) is an open access journal that concentrates on the discovery, development, and validation of assays, instruments, and technologies with the potential to facilitate accurate detection of dementia in its various forms and stages. Of particular interest are promising dementia biomarkers, ranging from gene expression and proteomic markers, to imaging, cognitive and functional markers of disease progression or treatment response. Review our Author Guidelines and submit your manuscript to DADM.


Journal Details

Journal title Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring (ADDADM)
Abbreviation Alzheimers Dement (Amst)
Online ISSN 2352-8729
Publisher Name John Wiley and Sons
Editor-in-chief Liana G. Apostolova
Subject Category Medicine

Abbreviation

Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring Journal is Alzheimers Dement (Amst).


Ranking

The Ranking of the Journal in 2024 is 1509. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.


Impact Factor

The Journal's Impact Factor in 2024 is 5.3. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.

List of All Journal Impact Factors


SCImago

The Journal SCImago in 2024 is 1.847. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.


Acceptance Rate

The Acceptance Rate in 2024 is 51%. It is a measure that provides insight into the selectivity and competitiveness of a journal's editorial process.


H-Index

The Journal's H-Index in 2024 is 53. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.


Quartile

The Journal's Quartile is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.


Journal's Indexing

The Journal is indexed in (Indexing details)

PubMed Scopus Web of Science UGC Embase DOAJ

Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.


Journal's Metrics for 2024

Abbreviation Alzheimers Dement (Amst)
Access type Open Access
Acceptance rate 51%
Impact Factor 5.3
SJR 1.847
SNIP 1.311
Ranking 1509
CiteScore 8.4
H-Index 53

Editorial Board

The Editor-in-chief of the Journal is Liana G. Apostolova


Submission/Processing Fee (APC)

Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.

The APC/Submission (Publication) Fee of the Journal is For Non Member $2,310 USD / £1,680 GBP / €1,890 EUR, For Member $1,155 USD / £840 GBP / €945 EUR


Call for paper

Call for paper : The Journal invites original research contributions for consideration of publication in Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring journal.

Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.

for details about call for paper please visit to the official website of the journal to check the details about call for papers.


How to publish in Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring

Publishing in Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring involves the following steps:

  • Research: Conduct high-quality, impactful research in the field of Medicine.
  • Familiarize Yourself: Read and understand the aims and scope of Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring to ensure your work aligns with their focus.
  • Manuscript Preparation: Prepare your manuscript according to the Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring guidelines, including formatting, length, and referencing style.
  • Submission: Submit your manuscript through the journal's online submission system.

Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring FAQ

is journal indexed in PubMed?

Yes, the journal is indexed in PubMed.

is journal indexed in Scopus?

Yes, the journal is indexed in Scopus.

is journal indexed in UGC?

Yes, the journal is indexed in UGC.

is journal indexed in Index Copernicus?

No, the journal is not indexed in Index copernicus.

is a predatory journal?

No, journal is not a predatory journal.

What is the Imptact Factor of Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring?

The Impact Factor of the Journal is 5.3.

What is the Ranking of the Journal?

The Ranking of the Journal is 1509.

is journal peer reviewed?

Yes the journal is a peer-reviewed journal.

is Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring a good journal?

Yes the journal is a peer-reviewed journal and good to publish your paper.

What is Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring?

Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring (ADDADM) is a scholarly journal dedicated to publishing research in the field of Medicine. John Wiley and Sons is the publisher of this esteemed journal.

is Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring open access?

Yes, Alzheimers and Dementia Diagnosis Assessment and Disease Monitoring is a open access journal.


Table of Contents

Who we are? Clarification: Journals Insights - Your Open Access Ally
Search For Journals, Indexing, Impact Factor etc.